{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:59:19Z","timestamp":1792450759300,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.tracli.2022.09.066","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T12:40:09Z","timestamp":1663936809000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Significance of mandating a dedicated hemovigilance nurse and objectification of \u2018imputability\u2019 levels. Experience from a hospital-based blood centre in India"],"prefix":"10.1016","volume":"30","author":[{"given":"Yashaswi","family":"Dhiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Raturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Kala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Kusum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2022.09.066_b0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1423-0410.2010.01442.x","article-title":"Hemovigilance: An effective tool for improving transfusion practice","volume":"100","author":"De Vries","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2022.09.066_b0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1751-2824.2009.01227.x","article-title":"Hemovigilance: Recent achievements and developments in the near future","volume":"4","author":"De Vries","year":"2009","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2022.09.066_b0015","unstructured":"Mission, Vision and Strategic goals: International Hemovigilance Network.Available from : https:\/\/www.ihn-org.com\/about\/mission-vision-strategic-goals."},{"key":"10.1016\/j.tracli.2022.09.066_b0020","unstructured":"A guide to establishing a National Hemovigilance System: World Health Organisation; 2016 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241549844."},{"key":"10.1016\/j.tracli.2022.09.066_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ajts.AJTS_5_18","article-title":"Hemovigilance Programme of India: Analysis of transfusion reactions reported from January 2013 to April 2016 and key recommendations for blood safety","volume":"12","author":"Bisht","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2022.09.066_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1751-2824.2011.01537.x","article-title":"The role of the transfusion nurse in the hospital and blood Centre","volume":"6","author":"Bielby","year":"2011","journal-title":"ISBT Sci Ser"},{"issue":"2","key":"10.1016\/j.tracli.2022.09.066_b0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/apjon.apjon_50_20","article-title":"bedside blood transfusion \u2013 what nurses Knowand perform: A cross-sectional study from ATertiary-Level Cancer Hospital in Rural Kerala","volume":"8","author":"Jogi","year":"2021","journal-title":"Asia-Pacific J Oncol Nurs"},{"key":"10.1016\/j.tracli.2022.09.066_b0040","series-title":"Rossi's principles of transfusion medicine","first-page":"694","article-title":"Overview of hemovigilance","author":"Stainsby","year":"2009"},{"key":"10.1016\/j.tracli.2022.09.066_b0045","unstructured":"Proposed Standard Definitions for surveillance of non-infectious adverse transfusion reactions JULY 2011 incorporating correction to TRALI definition (as adopted June 2013). ISBT working party on hemovigilance Available from: http:\/\/www.isbtweb.org\/fileadmin\/user_upload\/Proposed_definitions_2011_ surveillance_non_infectious_adverse_reactions_hemovigilance_incl_TRALI_ correction_2013.pdf."},{"key":"10.1016\/j.tracli.2022.09.066_b0050","unstructured":"Global Status Report on Blood Safety and Availability. World Health Organisation; 2016."},{"issue":"2","key":"10.1016\/j.tracli.2022.09.066_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/ajts.ajts_192_20","article-title":"Hemovigilance Programme of India: Comparative analysis of transfusion reactions reported over a 5-year period through two reporting formats and key recommendations for blood safety","volume":"14","author":"Bisht","year":"2020","journal-title":"Asian J Transfus Sci"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782022003093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782022003093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:44Z","timestamp":1761129644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782022003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1246782022003093"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2022.09.066","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of mandating a dedicated hemovigilance nurse and objectification of \u2018imputability\u2019 levels. Experience from a hospital-based blood centre in India","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2022.09.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}